ANNOUNCEMENT

Check out the MedCity CONVERGE speaker lineup: Pfizer, Cleveland Clinic, Intel and more.

Minnesota hypertension treatment firm names new chief commercial officer

July 9, 2012 1:21 pm by | 0 Comments

Privately held CVRx that has created an implantable device to treat high blood pressure announced Monday that it has named Philippe Wanstok to the newly created position of chief commercial officer.

Wanstok will oversee the worldwide commercialization of the neurostimulation product called the Barostim Neo, which bear the CE Mark and is currently available in Germany, Italy, The Netherlands, Switzerland and Austria. While the device received European approval in August 2011, it has run into some difficulties in the U.S.

Previously Wanstok was International General Manager of Commercial Operations with theCardiac Rhythm Disease Management division at Medtronic. He led a worldwide team of 3,000 and the business generated more than $2.4 billion of revenues in active implantable devices.

“We are thrilled to have Philippe join the CVRx team,’ said Nadim Yared, President and CEO of CVRx, in a news release. “Philippe’s consistently superb track record of accomplishments in the active implantable medical device market makes him ideally suited to lead CVRx’s worldwide commercial activities.”

Advertisement

An improvement upon the original Rheos system, the Barostim neo provides electrical stimulation to activate the baroreceptors – the blood pressure sensors responsible for cardiovascular function.

However, in the U.S. the company has found it difficult to get its device approved.

“We had a trial in the U.S. but it didn’t meet the clinical endpoint,” said John Brintnall, CVRx’s CFO in a phone interview. “We are in discussions with the FDA to design a new one and hope to have that started some time in 2012.”

 

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.

Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.


Related Topics: , ,

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Next Story
Drug to treat one of leading causes of blindness in Phase 3 trials
Close